Aurora Cannabis Inc cash flow statement
In fiscal 2026, Aurora Cannabis Inc's operations generated −$9.8m of cash; it spent $0 on capital projects, leaving free cash flow of −$9.8m.
Cash flow statement
| Fiscal year | 2019Jun 2018 | 2020Jun 2019 | 2021Jun 2020 | 2022Jun 2021 | 2023Jun 2022 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −64 | −145 | −255 | −164 | −87 | −51 | 12 | −10 |
| Depreciation and amortisation | 10 | 48 | 50 | 38 | 38 | 9 | 2 | 3 |
| Stock-based pay | 29 | 81 | 44 | 16 | 11 | 9 | 8 | 5 |
| Capital spending | 108 | 313 | — | 41 | 25 | 0 | 0 | 0 |
| Free cash flow | −172 | −458 | — | −206 | −113 | −51 | 12 | −10 |
| Free cash flow after stock pay | −202 | −539 | — | −222 | −123 | −60 | 3 | −15 |
Compare with peers
- Vanda Pharmaceuticals Inc. cash flow
- Harrow, Inc. cash flow
- Organigram Global Inc. cash flow
- Biote Corp. cash flow
- Kamada LTD cash flow
Head to head: ACB vs VNDAACB vs HROWACB vs OGI
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies